The Galanin Receptor Type 2 Initiates Multiple Signaling Pathways in Small Cell Lung Cancer Cells by Coupling to Gq, Gi And

Total Page:16

File Type:pdf, Size:1020Kb

The Galanin Receptor Type 2 Initiates Multiple Signaling Pathways in Small Cell Lung Cancer Cells by Coupling to Gq, Gi And Oncogene (2000) 19, 4199 ± 4209 ã 2000 Macmillan Publishers Ltd All rights reserved 0950 ± 9232/00 $15.00 www.nature.com/onc The galanin receptor type 2 initiates multiple signaling pathways in small cell lung cancer cells by coupling to Gq,Gi and G12 proteins Norbert Wittau1, Robert Grosse1, Frank Kalkbrenner1,3, Antje Gohla1,GuÈ nter Schultz1 and Thomas Gudermann*,2 1Institut fuÈr Pharmakologie, UniversitaÈtsklinikum Benjamin Franklin, Freie UniversitaÈt Berlin, 14195 Berlin, Germany; 2Institut fuÈr Pharmakologie und Toxikologie, Fachbereich Humanmedizin, Philipps-UniversitaÈt Marburg, Karl-von-Frisch-Str. 1, 35033 Marburg, Germany Neuropeptides like galanin produced and released by mutations or overexpression of receptor tyrosine small cell lung cancer (SCLC) cells are considered kinases are usually not encountered in SCLC, and the principal mitogens in these tumors. We identi®ed the expression of GTPase-de®cient Ras mutants or of a galanin receptor type 2 (GALR2) as the only galanin constitutively active Raf kinase induces growth arrest receptor expressed in H69 and H510 cells. Photoanity and apoptosis (Dhanasekaran et al., 1995; Ravi et al., labeling of G proteins in H69 cell membranes revealed 1998). These ®ndings lend credibility to the belief that that GALR2 activates G proteins of three subfamilies: the main driving force for growth and proliferation of 2+ Gq,Gi, and G12. In H69 cells, galanin-induced Ca this subtype of cancer is represented by various mobilization was pertussis toxin-insensitive. While neuropeptides, e.g. bombesin/gastrin-releasing peptide phorbol ester-induced extracellular signal-regulated ki- (GRP), bradykinin, cholecystokinin, gastrin, neuroten- nase (ERK) activation required protein kinase C (PKC) sin, vasopressin and galanin which stimulate SCLC cells activity, preincubation of H69 cells with the PKC- via multiple auto- and paracrine loops (Rozengurt, inhibitor GF109203X had no eect on galanin-dependent 1999). Consequently, neuropeptide-induced signal ERK activity. A rise of the intracellular calcium transduction pathways have attracted considerable concentration was necessary and sucient to mediate attention as they may provide potential targets for galanin-induced ERK activation. In support of Gi novel therapeutic strategies aimed at interfering with coupling, stimulation of GALR2 expressed in HEK293 growth stimulatory autocrine loops. Many neuropep- cells inhibited isoproterenol-induced cAMP accumulation tides and their corresponding cell surface receptors are and raised cAMP levels in COS-7 cells when coex- expressed in SCLC cells (Bepler et al., 1988; Moody et pressed with a chimeric GaS-Gai protein. In H69 cells, al., 1985). Various SCLC cell lines, like H69 and H510, galanin activated the monomeric GTPase RhoA and are generally employed as suitable in vitro models to induced stress ®ber formation in Swiss 3T3 cells study the molecular mechanisms of the mitogenic expressing GALR2. Thus, we provide the ®rst direct activity of neuropeptides in SCLC. evidence that in SCLC the mitogenic neuropeptide Neuropeptides exert their cellular eects by binding galanin, interacting with GALR2, simultaneously acti- to G-protein-coupled receptors (GPCRs), a large and vates multiple classes of G proteins and signals through diverse superfamily of proteins characterized by a the Gq phospholipase C/calcium sequence and a G12/Rho seven-transmembrane structure (Gudermann et al., pathway. Oncogene (2000) 19, 4199 ± 4209. 1997; SchoÈ neberg et al., 1999; Strader et al., 1994). Agonist-bound neuropeptide receptors transmit infor- Keywords: G-protein-coupled receptor; mitogenic sig- mation into the cell by activating regulatory guanine naling; multiple signaling; neuropeptides nucleotide-binding proteins (G proteins) composed of a, b, and g subunits. G proteins are classi®ed based upon primary sequence similarity of their a subunits Introduction and are subdivided into four families: Gs,Gi,Gq,G12 (Simon et al., 1991). Receptor activation initiates the Approximately 25% of all primary carcinomas of the exchange of GDP for GTP in the G-protein a subunit lung are classi®ed histologically as small cell lung cancer followed by dissociation of the G-protein heterotrimer (SCLC), a subtype which is characterized by rapid into a GTP-bound a subunit and a bg dimer. Both, Ga- growth and a high metastatic potential, giving rise to a GTP and Gbg are signaling molecules in their own 5-year survival rate of only 5% despite initial radio- and right and activate a diverse array of eector systems chemosensitivity (Lassen et al., 1995). Therefore, such as enzymes and ion channels (Birnbaumer et al., considerable eort is currently being devoted to the 1990; Clapham and Neer, 1997; Gautam et al., 1998; design of novel therapeutic approaches, which are based Hepler and Gilman, 1992). In recent years it has on an advanced understanding of the tumor biology of become evident that receptor/G protein systems play SCLC. In contrast to non-SCLC, transforming Ras an important role in cell dierentiation, proliferation and even in transformation by engaging signal transduction pathways like MAPK cascades which are classically employed by growth factors such as *Correspondence: T Gudermann EGF or PDGF (Dhanasekaran et al., 1995, 1998; 3 Current address: Atemwegsforschung, Boehringer Ingelheim Pharma Gutkind, 1998; van Biesen et al., 1996). In addition, KG, D-55216 Ingelheim, Germany Received 9 December 1999; revised 23 June 2000; accepted 3 July GTPase-de®cient G-protein a subunits can induce a 2000 transformed phenotype in certain ®broblast cell lines, Galanin signal transduction in SCLC cells N Wittau et al 4200 and mutationally activated G-protein a subunits have 1991a). In order to determine which galanin receptor been identi®ed in human tumors (Dhanasekaran et al., subtypes, GALR1, GALR2 or GALR3, are expressed 1995, 1998). in these cells, total RNA from H69 and H510 cells was The neuropeptide galanin was among the ®rst isolated, and a reverse transcription polymerase chain peptide growth factors for which a mitogenic eect reaction was performed. Ampli®cation products of the on SCLC cells was demonstrated (Sethi et al., 1992; expected size were obtained only with primers speci®c Sethi and Rozengurt, 1991a,b). Galanin is a 29-amino for the GALR2 (Figure 1, lanes 4 and 5). The primer acid (30 in men) polypeptide which is abundantly combinations used were tested by amplifying the expressed in brain as well as in peripheral tissues. The corresponding receptor fragments using a human brain regulation of a variety of physiological processes like library (Superscript cDNA library, Gibco ± BRL) as a stimulation of food intake, nociception, memory, template (data not shown), and the identity of the PCR depression, and control of neuroendocrine hypothala- products was con®rmed by direct DNA sequencing. In mic-pituitary circuits has been correlated with galanin the two tumor cell lines examined, neither GALR1 nor and its receptors (Bartfai et al., 1993; Bedecs et al., GALR3 were detected (Figure 1, lanes 1, 2 and 7, 8 1995; Kask et al., 1995; Wang and Gustafson, 1998). respectively) suggesting that galanin-mediated eects in In pituitary GH3 cells and in the pancreatic b-cell these SCLC cells are exclusively mediated by GALR2. model RINm5F, galanin interferes with hormone release by inhibition of voltage-gated Ca2+ channels Photoaffinity labeling of galanin-activated G-proteins in (Kalkbrenner et al., 1995). In H69 and H510 SCLC H69 cells cells, galanin challenge does not aect the membrane potential but causes a rapid and transient rise of the To identify the G proteins which couple to the agonist- 2+ 2+ intracellular Ca concentration [Ca ]i in a pertussis bound GALR2 in H69 cells, we resorted to the toxin-insensitive manner and stimulates the clonal approach of photoanity labeling of receptor-activated growth of SCLC cells in semisolid medium (Sethi and G-proteins in conjunction with selective immunopreci- Rozengurt, 1991a). The growth-stimulatory eect of pitation of radioactively labeled G-protein a subunits galanin on SCLC cells is mediated by the ERK (Laugwitz et al., 1994). Membranes of H69 cells were subfamily of mitogen-activated protein kinases incubated with or without 1 mM galanin in the presence (MAPKs), which are activated by galanin in a PKC- of the non-hydrolysable GTP-analog [a-32P]GTP azi- dependent fashion (Seuerlein and Rozengurt, 1996). doanilide. After UV cross-linking of the photolabel, G- The fact that galanin initiates an entirely dierent set protein a subunits were immunoprecipitated by speci®c of early events in SCLC cells as compared to pituitary antisera, resolved on SDS polyacrylamide gels and or pancreatic endocrine cells, supports the hypothesis visualized by autoradiography. As shown in Figure 2a, that galanin receptors expressed in SCLC cells are treatment of H69 cell membranes with galanin resulted distinct from those mediating the inhibitory eects on in increased incorporation of radioactivity into Gaq/11 neurotransmission and secretion in neuronal and proteins. In addition, galanin challenge of H69 endocrine cells, respectively. As yet, three galanin membranes caused signi®cant labeling of Ga12, minor 32 receptor subtypes, denoted GALR1, GALR2, and [a- P]GTP azidoanilide binding to Ga13 and small but GALR3, have been cloned which dier in their ligand reproducible agonist-induced photo anity labeling of binding and signal transduction characteristics (Wang Gai. The reduced incorporation of radioactivity into and Gustafson, 1998). So far, the molecular identity Ga13 as compared to Ga12 proteins cannot be simply and the G-protein coupling pro®le of the galanin explained by reduced Ga13 protein expression in H69 receptor expressed in SCLC cells remain elusive. membranes, since both, Ga12 and Ga13, were clearly In the present study, we show that GALR2 is the detectable by immunoblotting (Figure 2b). Likewise, in only galanin receptor subtype expressed in SCLC cells. the same membrane preparation Gas,Gaq/11, and Gai For the ®rst time, direct evidence is presented that in SCLC cells as well as in several heterologous cell systems GALR2 couples to members of three G- protein sub-families, i.e. Gq,Gi and G12.
Recommended publications
  • The Role of Kisspeptin Neurons in Reproduction and Metabolism
    238 3 Journal of C J L Harter, G S Kavanagh Kisspeptin, reproduction and 238:3 R173–R183 Endocrinology et al. metabolism REVIEW The role of kisspeptin neurons in reproduction and metabolism Campbell J L Harter*, Georgia S Kavanagh* and Jeremy T Smith School of Human Sciences, The University of Western Australia, Perth, Western Australia, Australia Correspondence should be addressed to J T Smith: [email protected] *(C J L Harter and G S Kavanagh contributed equally to this work) Abstract Kisspeptin is a neuropeptide with a critical role in the function of the hypothalamic– Key Words pituitary–gonadal (HPG) axis. Kisspeptin is produced by two major populations of f Kiss1 neurons located in the hypothalamus, the rostral periventricular region of the third f hypothalamus ventricle (RP3V) and arcuate nucleus (ARC). These neurons project to and activate f fertility gonadotrophin-releasing hormone (GnRH) neurons (acting via the kisspeptin receptor, f energy homeostasis Kiss1r) in the hypothalamus and stimulate the secretion of GnRH. Gonadal sex steroids f glucose metabolism stimulate kisspeptin neurons in the RP3V, but inhibit kisspeptin neurons in the ARC, which is the underlying mechanism for positive- and negative feedback respectively, and it is now commonly accepted that the ARC kisspeptin neurons act as the GnRH pulse generator. Due to kisspeptin’s profound effect on the HPG axis, a focus of recent research has been on afferent inputs to kisspeptin neurons and one specific area of interest has been energy balance, which is thought to facilitate effects such as suppressing fertility in those with under- or severe over-nutrition.
    [Show full text]
  • Bone-Specific Master Transcription Factor Runx2 Regulates Signaling and Metabolism Related Programs in Osteoprogenitors
    ISSN 0233-7657. Biopolymers and Cell. 2010. Vol. 26. N 4 Bone-specific master transcription factor Runx2 regulates signaling and metabolism related programs in osteoprogenitors N. M. Teplyuk1, 2, V. I. Teplyuk2 1University of Massachusetts Medical School 55, Lake Ave North, 01655, Worcester, MA, USA 2Institute of Molecular Biology and Genetics of National Academy of Sciences of Ukraine 150, Zabolotnogo str., Kiev, Ukraine, 03680 [email protected] Aim. Runx2 (AML3) transcription factor is the key regulator of osteoblastic lineage progression and is indispensable for the formation of mineral bones. Runx2 expression increases during differentiation of osteoblasts to induce osteoblast-specific genes necessary for the production and deposition of bone mineral matrix. However, Runx2 is also expressed at a lower level in early osteoprogenitors, where its function is less understood. Here we study how Runx2 determines the early stages of osteoblastic commitment using the model system of Runx2 re-introduction in mouse calvaria cells with Runx2 null background. Method. Affymetrix analysis, Western blot analysis and quantitative real-time reverse transcriptase PCR (qRT-PCR) analysis were employed. Results. Gene expression profiling by Affymetrix microarrays revealed that along with the induction of extracellular matrix and bone mineral deposition related phenotypic markers, Runx2 regulates several cell programs related to signaling and metabolism in the early osteoprogenitors. Particularly, Runx2 regulates transcription of genes involved in G-protein coupled signaling network, FGF and BMP/TGF beta signaling pathways and in biogenesis and metabolism pathways of steroid hormones. Conclusion. The data indicate that the lineage specific program, regulated by the master regulatory transcription factor, includes the regulation of cellular signaling and metabolism which may allow the committed cell to react and behave differently in the same microenvironment.
    [Show full text]
  • Serum Levels of Spexin and Kisspeptin Negatively Correlate with Obesity and Insulin Resistance in Women
    Physiol. Res. 67: 45-56, 2018 https://doi.org/10.33549/physiolres.933467 Serum Levels of Spexin and Kisspeptin Negatively Correlate With Obesity and Insulin Resistance in Women P. A. KOŁODZIEJSKI1, E. PRUSZYŃSKA-OSZMAŁEK1, E. KOREK4, M. SASSEK1, D. SZCZEPANKIEWICZ1, P. KACZMAREK1, L. NOGOWSKI1, P. MAĆKOWIAK1, K. W. NOWAK1, H. KRAUSS4, M. Z. STROWSKI2,3 1Department of Animal Physiology and Biochemistry, Poznan University of Life Sciences, Poznan, Poland, 2Department of Hepatology and Gastroenterology & The Interdisciplinary Centre of Metabolism: Endocrinology, Diabetes and Metabolism, Charité-University Medicine Berlin, Berlin, Germany, 3Department of Internal Medicine, Park-Klinik Weissensee, Berlin, Germany, 4Department of Physiology, Karol Marcinkowski University of Medical Science, Poznan, Poland Received August 18, 2016 Accepted June 19, 2017 On-line November 10, 2017 Summary Corresponding author Spexin (SPX) and kisspeptin (KISS) are novel peptides relevant in P. A. Kolodziejski, Department of Animal Physiology and the context of regulation of metabolism, food intake, puberty and Biochemistry, Poznan University of Life Sciences, Wolynska Street reproduction. Here, we studied changes of serum SPX and KISS 28, 60-637 Poznan, Poland. E-mail: [email protected] levels in female non-obese volunteers (BMI<25 kg/m2) and obese patients (BMI>35 kg/m2). Correlations between SPX or Introduction KISS with BMI, McAuley index, QUICKI, HOMA IR, serum levels of insulin, glucagon, leptin, adiponectin, orexin-A, obestatin, Kisspeptin (KISS) and spexin (SPX) are peptides ghrelin and GLP-1 were assessed. Obese patients had lower SPX involved in regulation of body weight, metabolism and and KISS levels as compared to non-obese volunteers (SPX: sexual functions. In 2014, Kim and coworkers showed that 4.48±0.19 ng/ml vs.
    [Show full text]
  • Purification of a Galanin Receptor from Pig Brain
    Proc. Natl. Acad. Sci. USA Vol. 90, pp. 3845-3849, May 1993 Neurobiology Purification of a galanin receptor from pig brain YAOHUI CHEN*, ALAIN FOURNIERt, ALAIN COUVINEAU*, MARC LABURTHE*, AND BRIGITTE AMIRANOFF*t *Laboratoire de Biologie and Physiologie des Cellules Digestives, Institut National de la Sant6 et de la Recherche Mddicale, U 239, 16 Rue Henri Huchard-75018 Paris, France; and tUniversitd du Quebec, Institut National de la Recherche Scientifique, INRS-Santd, 245 Boulevard Hymus, Pointe Claire, Qudbec, H9R1G6, Canada Communicated by Tomas Hokfelt, January 4, 1993 ABSTRACT A galanin receptor protein was solubilized lished data), we report the purification of a galanin receptor with 3-[(3-cholamidopropyl)dimethylammonio]-1-propane- from pig brain, a rich source of receptors that is available in sulfonate (CHAPS) from pig brain membranes and then pu- large amounts. This represents a basic step toward knowl- rified by single-step affinity chromatography. The product edge of the pharmacology and biochemistry of galanin re- exhibits saturable and specific binding for galanin with a ceptors and should lead to a better understanding of their binding activity of 17 nmol/mg of protein and a dissociation expression in the organism. constant (Kd) of 10 nM. This represents a 300,000-fold puri- fication over the detergent-solubilized fraction with a final recovery of 31% of the initial membrane galanin binding METHODS activity. Gel electrophoresis of the affinity-purified material Materials. Synthetic porcine galanin, glucagon, vasoactive showed a single polypeptide of 54 kDa by silver staining and intestinal peptide, synthetic neurotensin, substance P, baci- after radioiodination. Cross-linking of a purified fraction af- tracin, leupeptin, pepstatin A, GTP, GDP, guanosine 5'-[13,v- rmity-labeled with 125I-labeled galanin revealed a single band imido]triphosphate, cholesteryl hemisuccinate, 3-[(3-cholami- for the galanin-receptor complex at 57 kDa.
    [Show full text]
  • Galanin Stimulates Cortisol Secretion from Human Adrenocortical Cells
    859-864 9/11/07 11:36 Page 859 INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 20: 859-864, 2007 859 Galanin stimulates cortisol secretion from human adrenocortical cells through the activation of galanin receptor subtype 1 coupled to the adenylate cyclase-dependent signaling cascade ANNA S. BELLONI1, LUDWIK K. MALENDOWICZ2, MARCIN RUCINSKI2, DIEGO GUIDOLIN1 and GASTONE G. NUSSDORFER1 1Department of Human Anatomy and Physiology, School of Medicine, University of Padua, I-35121 Padua, Italy; 2Department of Histology and Embryology, Poznan School of Medicine, PL-60781 Poznan, Poland Received September 10, 2007; Accepted October 5, 2007 Abstract. Previous studies showed that galanin receptors are Introduction expressed in the rat adrenal, and galanin modulates gluco- corticoid secretion in this species. Hence, we investigated the Galanin is a regulatory peptide (30 amino acid residues in expression of the various galanin receptor subtypes (GAL-R1, humans) originally isolated from pig intestine (1) which is GAL-R2 and GAL-R3) in the human adrenocortical cells, and widely distributed in the central and peripheral nervous the possible involvement of galanin in the control of cortisol system, where it acts as a neurotransmitter/neuromodulator. secretion. Reverse transcription-polymerase chain reaction In the gut, galanin modulates insulin release and intestine detected the expression of GAL-R1 (but not GAL-R2 and contractility (2,3). Galanin acts through three distinct subtypes GAL-R3) in the inner zones of the human adrenal cortex. The of G protein-coupled receptors, referred to as GAL-R1, GAL-R2 galanin concentration dependently enhanced basal, but not and GAL-R3 (4). ACTH-stimulated secretion of cortisol from dispersed inner Evidence suggests that galanin is involved in the functional adrenocortical cells (maximal effective concentration, 10-8 M).
    [Show full text]
  • Characterization of a High-Affinity Galanin Receptor in the Rat
    Proc. Natl. Acad. Sci. USA Vol. 90, pp. 4231-4235, May 1993 Neurobiology Characterization of a high-affinity galanin receptor in the rat anterior pituitary: Absence of biological effect and reduced membrane binding of the antagonist M15 differentiate it from the brain/gut receptor (galanin fragment/hemolytic plaque technique/prolactin) DAVID WYNICK*, DAVID M. SMITH*, MOHAMMAD GHATEI*, KAREN AKINSANYA*, RANJEV BHOGAL*, PAUL PURKISSt, PETER BYFIELDt, NOBORU YANAIHARAt, AND STEPHEN R. BLOOM* *Department of Medicine, Hammersmith Hospital, London W12 ONN, United Kingdom; tHaemostasis Research Group, Clinical Research Centre, Harrow, Middlesex, HAl 3UJ, United Kingdom; and tDepartment of Bio-organic Chemistry, University of Shizuoka, Shizuoka, Japan Communicated by L. L. Iversen, December 30, 1992 (received for review November 24, 1992) ABSTRACT Structure-activity studies demonstrate that anterior pituitary, where it has been shown to be estrogen galanin fragments 1-15 and 2-29 are fully active, whereas inducible (5). fragment 3-29 has been reported to be inactive, in a number Various studies have demonstrated effects of galanin on ofdifferent in vivo models. M15, a chimeric peptide comprising basal and stimulated release of prolactin (6, 7), growth galanin 1-13 and substance P 5-11, has recently been found to hormone (8-11), and luteinizing hormone (12, 13) either from be a potent galanin antagonist. Direct effects of galanin at the dispersed pituitary cells or at the hypothalamic level modu- level of the pituitary have been defined, yet, paradoxically, a lating dopamine, somatostatin (SRIF; somatotropin release- number of studies have been unable to demonstrate galanin inhibiting factor), and gonadotropin-releasing hormone binding to an anterior pituitary receptor.
    [Show full text]
  • Focus on Cdc42 in Breast Cancer: New Insights, Target Therapy Development and Non-Coding Rnas
    Review Focus on Cdc42 in Breast Cancer: New Insights, Target Therapy Development and Non-Coding RNAs Yu Zhang †, Jun Li †, Xing-Ning Lai, Xue-Qiao Jiao, Jun-Ping Xiong and Li-Xia Xiong * Department of Pathophysiology, Jiangxi Province Key Laboratory of Tumor Pathogenesis and Molecular Pathology, Medical College, Nanchang University, 461 Bayi Road, Nanchang 330006, China; [email protected] (Y.Z.); [email protected] (J.L.); [email protected] (X.-N.L.); [email protected] (X.-Q.J.); [email protected] (J.-P.X.) * Correspondence: [email protected]; Tel.: +86-791-8636-0556 † These authors contributed equally to this work. Received: 30 December 2018; Accepted: 8 February 2019; Published: 11 February 2019 Abstract: Breast cancer is the most common malignant tumors in females. Although the conventional treatment has demonstrated a certain effect, some limitations still exist. The Rho guanosine triphosphatase (GTPase) Cdc42 (Cell division control protein 42 homolog) is often upregulated by some cell surface receptors and oncogenes in breast cancer. Cdc42 switches from inactive guanosine diphosphate (GDP)-bound to active GTP-bound though guanine-nucleotide- exchange factors (GEFs), results in activation of signaling cascades that regulate various cellular processes such as cytoskeletal changes, proliferation and polarity establishment. Targeting Cdc42 also provides a strategy for precise breast cancer therapy. In addition, Cdc42 is a potential target for several types of non-coding RNAs including microRNAs and lncRNAs. These non-coding RNAs is extensively involved in Cdc42-induced tumor processes, while many of them are aberrantly expressed. Here, we focus on the role of Cdc42 in cell morphogenesis, proliferation, motility, angiogenesis and survival, introduce the Cdc42-targeted non-coding RNAs, as well as present current development of effective Cdc42-targeted inhibitors in breast cancer.
    [Show full text]
  • Reorganization of Neural Peptidergic Eminence After Hypophysectomy
    The Journal of Neuroscience, October 1994, 14(10): 59966012 Reorganization of Neural Peptidergic Systems Median Eminence after Hypophysectomy Marcel0 J. Villar, Bjiirn Meister, and Tomas Hiikfelt Department of Neuroscience, The Berzelius Laboratory, Karolinska Institutet, Stockholm, 171 77 Sweden Earlier studies have shown the formation of a novel neural crease to a final stage of a few, strongly immunoreactive lobe after hypophysectomy, an experimental manipulation fibers in the external layer at longer survival times. Vaso- that causes transection of neurohypophyseal nerve fibers active intestinal polypeptide (VIP)- and peptide histidine- and removal of pituitary hormones. The mechanisms that isoleucine (PHI)-IR fibers in hypophysectomized animals had underly this regenerative process are poorly understood. already contacted portal vessels 5 d after hypophysectomy, The localization and number of peptide-immunoreactive and from then on progressively increased in numbers. Fi- (-IR) fibers in the median eminence were studied in normal nally, most of the peptide fibers described above formed rats and in rats at different times of survival after hypophy- dense innervation patterns around the large blood vessels sectomy using indirect immunofluorescence histochemistry. along the lateral borders of the median eminence. The number of vasopressin (VP)-IR fibers increased in the The present results show that hypophysectomy induces external layer of the median eminence in 5 d hypophysec- a wide variety of changes in hypothalamic neurosecretory tomized rats. Oxytocin (OXY)-IR fibers decreased in the in- fibers. Not only is the expression of several peptides in these ternal layer and progressively extended into the external fibers modified following different survival times, but a re- layer.
    [Show full text]
  • Small Rho Gtpase Family Member Cdc42 and Its Role in Neuronal Survival and Apoptosis
    University of Denver Digital Commons @ DU Electronic Theses and Dissertations Graduate Studies 1-1-2017 Small Rho GTPase Family Member Cdc42 and Its Role in Neuronal Survival and Apoptosis Noelle Christine Punessen University of Denver Follow this and additional works at: https://digitalcommons.du.edu/etd Part of the Biology Commons, and the Genetics and Genomics Commons Recommended Citation Punessen, Noelle Christine, "Small Rho GTPase Family Member Cdc42 and Its Role in Neuronal Survival and Apoptosis" (2017). Electronic Theses and Dissertations. 1337. https://digitalcommons.du.edu/etd/1337 This Thesis is brought to you for free and open access by the Graduate Studies at Digital Commons @ DU. It has been accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of Digital Commons @ DU. For more information, please contact [email protected],[email protected]. Small Rho GTPase Family Member Cdc42 and its Role in Neuronal Survival and Apoptosis A Thesis Presented to the Faculty of Natural Sciences and Mathematics University of Denver In Partial Fulfillment of the Requirements for the Degree Master of Science by Noelle C. Punessen August 2017 Advisor: Dr. Daniel A. Linseman Author: Noelle C. Punessen Title: Small Rho GTPase Family Member Cdc42 and its Role in Neuronal Survival and Apoptosis Advisor: Dr. Daniel A. Linseman Degree Date: August 2017 Abstract Neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Alzheimer’s and Parkinson’s disease are caused by a progressive and aberrant destruction of neurons in the brain and spinal cord. These disorders lack effective long term treatments, and existing options focus primarily on either delaying disease onset or alleviating symptomology.
    [Show full text]
  • Supplementary Information Method CLEAR-CLIP. Mouse Keratinocytes
    Supplementary Information Method CLEAR-CLIP. Mouse keratinocytes of the designated genotype were maintained in E-low calcium medium. Inducible cells were treated with 3 ug/ml final concentration doxycycline for 24 hours before performing CLEAR-CLIP. One 15cm dish of confluent cells was used per sample. Cells were washed once with cold PBS. 10mls of cold PBS was then added and cells were irradiated with 300mJ/cm2 UVC (254nM wavelength). Cells were then scraped from the plates in cold PBS and pelleted by centrifugation at 1,000g for 2 minutes. Pellets were frozen at -80oC until needed. Cells were then lysed on ice with occasional vortexing in 1ml of lysis buffer (50mM Tris-HCl pH 7.4, 100mM NaCl, 1mM MgCl2, 0.1 mM CaCl2, 1% NP-40, 0.5% Sodium Deoxycholate, 0.1% SDS) containing 1X protease inhibitors (Roche #88665) and RNaseOUT (Invitrogen #10777019) at 4ul/ml final concentration. Next, TurboDNase (Invitrogen #AM2238, 10U), RNase A (0.13ug) and RNase T1 (0.13U) were added and samples were incubated at 37oC for 5 minutes with occasional mixing. Samples were immediately placed on ice and then centrifuged at 16,160g at 4oC for 20 minutes to clear lysate. 25ul of Protein-G Dynabeads (Invitrogen #10004D) were used per IP. Dynabeads were pre-washed with lysis buffer and pre- incubated with 3ul of Wako Anti-Mouse-Ago2 (2D4) antibody. The dynabead/antibody mixture was added to the lysate and rocked for 2 hours at 4oC. All steps after the IP were done on bead until samples were loaded into the polyacrylamide gel.
    [Show full text]
  • Neurotransmitter and Neuropeptide Regulation of Mast Cell Function
    Xu et al. Journal of Neuroinflammation (2020) 17:356 https://doi.org/10.1186/s12974-020-02029-3 REVIEW Open Access Neurotransmitter and neuropeptide regulation of mast cell function: a systematic review Huaping Xu1, Xiaoyun Shi2, Xin Li3, Jiexin Zou4, Chunyan Zhou5, Wenfeng Liu5, Huming Shao5, Hongbing Chen5 and Linbo Shi4* Abstract The existence of the neural control of mast cell functions has long been proposed. Mast cells (MCs) are localized in association with the peripheral nervous system (PNS) and the brain, where they are closely aligned, anatomically and functionally, with neurons and neuronal processes throughout the body. They express receptors for and are regulated by various neurotransmitters, neuropeptides, and other neuromodulators. Consequently, modulation provided by these neurotransmitters and neuromodulators allows neural control of MC functions and involvement in the pathogenesis of mast cell–related disease states. Recently, the roles of individual neurotransmitters and neuropeptides in regulating mast cell actions have been investigated extensively. This review offers a systematic review of recent advances in our understanding of the contributions of neurotransmitters and neuropeptides to mast cell activation and the pathological implications of this regulation on mast cell–related disease states, though the full extent to which such control influences health and disease is still unclear, and a complete understanding of the mechanisms underlying the control is lacking. Future validation of animal and in vitro models also is needed, which incorporates the integration of microenvironment-specific influences and the complex, multifaceted cross-talk between mast cells and various neural signals. Moreover, new biological agents directed against neurotransmitter receptors on mast cells that can be used for therapeutic intervention need to be more specific, which will reduce their ability to support inflammatory responses and enhance their potential roles in protecting against mast cell–related pathogenesis.
    [Show full text]
  • Differential Gene Expression in Oligodendrocyte Progenitor Cells, Oligodendrocytes and Type II Astrocytes
    Tohoku J. Exp. Med., 2011,Differential 223, 161-176 Gene Expression in OPCs, Oligodendrocytes and Type II Astrocytes 161 Differential Gene Expression in Oligodendrocyte Progenitor Cells, Oligodendrocytes and Type II Astrocytes Jian-Guo Hu,1,2,* Yan-Xia Wang,3,* Jian-Sheng Zhou,2 Chang-Jie Chen,4 Feng-Chao Wang,1 Xing-Wu Li1 and He-Zuo Lü1,2 1Department of Clinical Laboratory Science, The First Affiliated Hospital of Bengbu Medical College, Bengbu, P.R. China 2Anhui Key Laboratory of Tissue Transplantation, Bengbu Medical College, Bengbu, P.R. China 3Department of Neurobiology, Shanghai Jiaotong University School of Medicine, Shanghai, P.R. China 4Department of Laboratory Medicine, Bengbu Medical College, Bengbu, P.R. China Oligodendrocyte precursor cells (OPCs) are bipotential progenitor cells that can differentiate into myelin-forming oligodendrocytes or functionally undetermined type II astrocytes. Transplantation of OPCs is an attractive therapy for demyelinating diseases. However, due to their bipotential differentiation potential, the majority of OPCs differentiate into astrocytes at transplanted sites. It is therefore important to understand the molecular mechanisms that regulate the transition from OPCs to oligodendrocytes or astrocytes. In this study, we isolated OPCs from the spinal cords of rat embryos (16 days old) and induced them to differentiate into oligodendrocytes or type II astrocytes in the absence or presence of 10% fetal bovine serum, respectively. RNAs were extracted from each cell population and hybridized to GeneChip with 28,700 rat genes. Using the criterion of fold change > 4 in the expression level, we identified 83 genes that were up-regulated and 89 genes that were down-regulated in oligodendrocytes, and 92 genes that were up-regulated and 86 that were down-regulated in type II astrocytes compared with OPCs.
    [Show full text]